Europe — EMA
Nuvaxovid Xbb.1.5 (Matrix M, Mivalsecovatein)
Matrix M, the active ingredient in Nuvaxovid Xbb.1.5, is a novel antiviral agent presented as a 0.5 ml pre‑filled syringe for intramuscular use.
Request sourcing
1
Pack/s
What is Matrix M, Mivalsecovatein?
Matrix M, the active ingredient in Nuvaxovid Xbb.1.5, is a novel antiviral agent presented as a 0.5 ml pre‑filled syringe for intramuscular use. It targets emerging variants of respiratory viruses in adults and older adolescents.
GNH USA supplies Nuvaxovid Xbb.1.5 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.
What is Matrix M, Mivalsecovatein used for?
Nuvaxovid Xbb.1.5 is designed to stimulate the immune response against the Xbb.1.5 variant of the SARS‑CoV‑2 virus and provides prevent prevent prevent - COVID‑19 (caused by the Xbb variant of S‑ … ").
What are the side effects of Matrix M, Mivalsecovatein?
Common ...
What precautions apply to Matrix M, Mivalsecovatein?
...
Product details
Drug
Matrix M, Mivalsecovatein
Route
Intramuscular Use
Manufacturer
Novavax Cz A.S.
Origin
EU
